Create Free Account

By creating account you will get access to hot stocks & personalised emails

BTC Health Limited

Healthcare AU BTC

0.071AUD
0.006(9.23%)

Last update at 2024-12-18T23:00:00Z

Day Range

0.070.07
LowHigh

52 Week Range

0.040.07
LowHigh

Fundamentals

  • Previous Close 0.07
  • Market Cap21.72M
  • Volume30928
  • P/E Ratio-
  • Dividend Yield-%
  • EBITDA-
  • Revenue TTM0.02M
  • Revenue Per Share TTM-
  • Gross Profit TTM 0.01M
  • Diluted EPS TTM-

Analyst Recommendations

Financials

Income Statement

Balancesheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2024-06-30 2023-06-30 2022-06-30 2021-06-30 2020-06-30
Type yearly yearly yearly yearly yearly
Date 2024-06-30 2023-06-30 2022-06-30 2021-06-30 2020-06-30
Income before tax 1.06M -10.16786M -0.57608M -0.39169M -0.28304M
Minority interest - - - - -
Net income 1.06M -10.16786M -0.57608M -0.39169M -0.28304M
Selling general administrative 0.34M 0.28M 0.29M 0.31M 0.44M
Selling and marketing expenses - 0.15M 0.26M 0.04M 0.05M
Gross profit 0.02M 0.01M 0.10M 0.02M 0.29M
Reconciled depreciation - - - - -
Ebit 1.06M -10.16786M -0.57608M -0.39169M -0.28304M
Ebitda 1.06M -10.16786M -0.57608M -0.39169M -0.05813M
Depreciation and amortization -0.00000M 0.49M 0.49M 0.33M 0.22M
Non operating income net other - - - - -
Operating income 1.06M -10.16786M -0.57608M -0.39169M -0.28304M
Other operating expenses 1.04M 10.18M 0.67M 0.41M 0.45M
Interest expense - - 0.00064M 0.00000M 0.00000M
Tax provision 0.00000M 0.00000M 0.00000M 0.00000M 0.00000M
Interest income 0.02M 9.62M 0.00064M 0.00086M 0.12M
Net interest income 0.02M 0.01M 0.00064M 0.00086M 0.00960M
Extraordinary items - - - - -
Non recurring - - - - -
Other items - - - - -
Income tax expense 1.06M -0.48796M -0.49175M -0.33028M 0.00000M
Total revenue 0.02M 0.01M 0.10M 0.02M 0.17M
Total operating expenses -1.03893M 10.18M 0.67M 0.41M 0.45M
Cost of revenue - - - - -0.12500M
Total other income expense net -0.00000M -9.67991M -0.08432M -0.06140M 0.00000M
Discontinued operations - - - - -
Net income from continuing ops 1.06M -10.16786M -0.57608M -0.39169M -0.28304M
Net income applicable to common shares - -10.16786M -0.57608M -0.39169M -0.28304M
Preferred stock and other adjustments - - - - -
Breakdown 2024-06-30 2023-06-30 2022-06-30 2021-06-30 2020-06-30
Type yearly yearly yearly yearly yearly
Date 2024-06-30 2023-06-30 2022-06-30 2021-06-30 2020-06-30
Total assets 5.15M 2.94M 13.02M 12.98M 11.46M
Intangible assets - - - - -
Earning assets - - - - -
Other current assets -2.02216M 0.00478M 0.00057M 0.00093M 0.01M
Total liab 0.20M 0.16M 0.16M 2.15M 0.23M
Total stockholder equity 4.94M 2.78M 12.86M 10.84M 11.23M
Deferred long term liab - - - - -
Other current liab - 0.15M 0.10M 2.11M 0.15M
Common stock 56.55M 55.67M 55.67M 53.27M 53.27M
Capital stock - 55.67M 55.67M 53.27M 53.27M
Retained earnings -52.11715M -53.17244M -43.00458M -42.60036M -42.25166M
Other liab - - - - -
Good will - - - - -
Other assets 5.15M - - - 2.10M
Cash 2.02M 1.74M 2.17M 2.37M 2.75M
Cash and equivalents - 1.74M 2.17M 2.37M 2.75M
Total current liabilities - 0.16M 0.16M 2.15M 0.23M
Current deferred revenue - - 0.10M 0.11M 0.11M
Net debt -2.02216M -1.73690M -2.17049M -2.36897M -2.75029M
Short term debt - 0.00000M -0.05913M -0.10658M -0.10673M
Short long term debt - - - - -
Short long term debt total - - - - -
Other stockholder equity - -2.49317M -12.66103M -10.66525M -11.01395M
Property plant equipment - - - - -
Total current assets - 1.74M 2.20M 4.98M 3.36M
Long term investments - 1.20M 10.82M 8.00M 6.00M
Net tangible assets - 2.78M 12.86M 10.84M 11.23M
Short term investments - - - 0.00000M 0.50M
Net receivables - - 0.03M 2.61M 0.05M
Long term debt - - - - -
Inventory - - - - 0.04M
Accounts payable - 0.01M 0.00558M 0.04M 0.08M
Total permanent equity - - - - -
Noncontrolling interest in consolidated entity - - - - -
Temporary equity redeemable noncontrolling interests - - - - -
Accumulated other comprehensive income 0.51M 0.29M 0.20M 0.17M 0.21M
Additional paid in capital - - - - -
Common stock total equity - - - - 53.27M
Preferred stock total equity - - - - -
Retained earnings total equity - - - - -
Treasury stock - - - - -
Accumulated amortization - - - - -
Non currrent assets other - -1.20000M -10.81989M -8.00010M -6.00010M
Deferred long term asset charges - - - - -
Non current assets total - 1.20M 10.82M 8.00M 8.10M
Capital lease obligations - - - - -
Long term debt total - 0.00000M 0.00000M 0.00000M 0.00000M
Breakdown 2024-06-30 2023-06-30 2022-06-30 2021-06-30 2020-06-30
Type yearly yearly yearly yearly yearly
Date 2024-06-30 2023-06-30 2022-06-30 2021-06-30 2020-06-30
Investments -0.19780M - -2.00000M 0.50M -0.86137M
Change to liabilities - 0.00614M 0.01M -0.08087M -0.03662M
Total cashflows from investing activities - 0.00000M -2.20557M -0.01516M -0.86137M
Net borrowings - - - - -
Total cash from financing activities 0.89M 0.00000M 2.40M 2.40M 0.16M
Change to operating activities - 0.02M -0.02826M 0.11M -0.05695M
Net income 1.06M -10.16786M -0.57608M -0.39169M -0.28304M
Change in cash 0.29M -0.43359M -0.19848M -0.38131M -1.19263M
Begin period cash flow 1.74M 2.17M 2.37M 2.75M 3.94M
End period cash flow 2.02M 1.74M 2.17M 2.37M 2.75M
Total cash from operating activities -0.40476M -0.43361M -0.39291M -0.36615M -0.49202M
Issuance of capital stock 0.89M - 2.50M - 0.16M
Depreciation - - - - -
Other cashflows from investing activities - 0.00000M -0.20557M -0.51516M -0.86137M
Dividends paid - - - - -
Change to inventory - - - - -
Change to account receivables - - - - -
Sale purchase of stock - 0.00000M -0.10000M -0.10000M 0.16M
Other cashflows from financing activities -0.19780M 0.00000M -2.20557M -0.01516M 0.16M
Change to netincome - 9.71M 0.20M 0.20M -0.11541M
Capital expenditures 0.00000M 0.00000M 0.00000M 0.00000M 0.00000M
Change receivables - - - - -
Cash flows other operating - - - - -
Exchange rate changes - - - - -
Cash and cash equivalents changes - - - - -
Change in working capital 0.03M 0.03M -0.01777M 0.03M -0.09358M
Stock based compensation - 0.09M 0.20M - 0.10M
Other non cash items -1.49298M 9.62M 0.19M 0.08M -0.21809M
Free cash flow -0.40476M -0.43361M -0.39291M -0.36615M -0.49202M

Peer Comparison

Sector: Healthcare Industry: Biotechnology

Company Change (AUD) Price (AUD) Trailing PE (x) Forward PE (x) Price Sales TTM (x) Price to Book Value (x) Enterprise Value to Revenue (x) Enterprise Value to EBITDA (x)
BTC
BTC Health Limited		 0.006 9.23% 0.07 - - 1327.40 3.87 68.18 -13.3097
CSL
CSL Ltd		 -3.45 1.22% 278.79 32.86 33.00 9.11 5.02 6.65 20.64
TLX
Telix Pharmaceuticals Ltd		 -0.07 0.27% 25.67 161.73 75.19 12.58 19.98 12.52 109.28
MSB
Mesoblast Ltd		 1.07 54.04% 3.05 - 454.55 312.43 2.49 67.90 -9.8623
NEU
Neuren Pharmaceuticals Ltd		 -0.36 2.79% 12.54 13.51 35.21 8.91 5.13 6.48 8.45

Reports Covered

Stock Research & News

View All

Profile

BTC Health Limited is a Pooled Development Fund managed by LHC Capital Partners Pty Ltd specializing in seed/startup, early venture, mid venture, late venture, emerging growth and growth capital investments. It makes investments in the healthcare and biotechnology sector with a focus on post-genomics, stem cell biology, convergence, silicon biology, and nanomedicine. Within post-genomics, it invests in functional genomics, transcriptomics, proteomics, structural genomics, glycomics, and pharmacogenomics. In the stem cell biology sector, the fund focuses on stem cell therapies. Within convergent technologies, it invests in biomaterials, bionics, biosensors, tissue engineering, microfluidics, and moletronics. In the silicon biology sector, the fund focuses on structure-based drug design, virtual screening, computational library design, and in silico ADME/tox. It invests in companies based in Australia New Zealand. The fund invests in both listed and unlisted companies.

BTC Health Limited

Suite 201, Camberwell, VIC, Australia, 3124

Key Executives

Name Title Year Born
Ms. Sharon Papworth C.A., B.Com., CA CFO & Company Sec. NA
Mr. Oskar Hakansson Bus. Devel. Director NA
Mr. Tim Collins Sales & Marketing Director NA
Mr. Joshua Kahanovitz Head of Finance NA
Mr. Oskar Hakansson Business Development Director NA
Ms. Tracy Weimar BA, MBA Company Secretary NA
Mr. Joshua Kahanovitz Head of Finance NA
Mr. Oskar Hakansson Business Development Director NA
Ms. Tracy Weimar BA, MBA Company Secretary NA
Mr. Joshua Kahanovitz Head of Finance NA

Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on ‘as is’ basis, using their API. The information and data provided on this page, as well as via the API, are not guaranteed to be real-time or accurate. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general informational purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine does not assume any responsibility for any trading losses you might incur as a result of using this information, data, or any analyst rating or recommendation provided. Kalkine will not accept any liability for any loss or damage resulting from reliance on the information, including but not limited to data, quotes, charts, analyst ratings, recommendations, and buy/sell signals sourced via the API.
Please be fully informed about the risks and costs associated with trading in the financial markets, as it is one of the riskiest forms of investment. Kalkine does not provide any warranties regarding the information on this page, including, without limitation, warranties of merchantability or fitness for a particular purpose or use.

Our Company

Useful Links

Contact Us

ISO Certified Market Research

Kalkine Solutions Private Limited, authorized representative of Kalkine Pty Ltd, holds ISO 27001:2022 certification bearing Certificate No.- IC-IS-2404072

Our Company

Useful Links

Contact Us

Disclaimer

The information given by Kalkine Pty Ltd ABN34 154 808 312 (Australian Financial Services License Number 425376) on this website is general information or advice only.

It does not take into account any of your personal objectives, circumstances or needs. Choosing an investment is an important decision. If you do not feel confident making a decision based on the recommendations Kalkine has made in our reports, you should consider obtaining personal advice from an authorised adviser.

There may be a product disclosure statement or other offer document for the securities and financial products we write about in Kalkine Reports. You should obtain a copy of the product disclosure statement or offer document before making any decision about whether to acquire the security or product. Terms & Conditions have been provided for our services, please go through them and also read our Financial Services Guide.

Our website may contain information on past performance of particular investments. Past performance is not an indicator of future performance. Hypothetical returns may not reflect actual performance. Any displays of potential investment opportunities are for sample purposes only and may not actually be available to investors.

The information on the website does not constitute an offer to sell securities or a solicitation of an offer to buy securities. Our reports contain general recommendations to invest in securities.

Copyright 2024 Krish Capital Pty. Ltd. All rights reserved. No part of this website, or its content, may be reproduced in any form without our prior consent.